Article
In vivo CYP2E1 phenotyping as a new potential biomarker of occupational and experimental exposure to benzene.
Toxicology letters - 15 Jan 2010
Piccoli P, Carrieri M, Padovano L, Di Mare M, Bartolucci G B, Fracasso M E, Lepera J S, Manno M
Abstract excerpt
Assessing CYP2E1 phenotype in vivo may be important to predict individual susceptibility to those chemicals, including benzene, which are metabolically activated by this isoenzyme. Chlorzoxazone (CHZ), a specific CYP2E1 substrate, is readily hydroxylated to 6-OH-chlorzoxazone (6-OH-CHZ) by liver CYP2E1 and the metabolic ratio 6-OH-CHZ/CHZ in serum (MR) is a specific and sensitive biomarker of CYP2E1 activity in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
